Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TTR | P02766 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31196527 | 1.00 | SUCNR1 (0.43) | SUCNR1HSD17B10TTRTSHRKDM4E | |
| SCHEMBL9514859 | 1.00 | SUCNR1 (0.43) | SUCNR1HSD17B10TTRTSHRKDM4E | |
| SCHEMBL9516478 | 1.00 | SUCNR1 (0.43) | SUCNR1HSD17B10TTRTSHRKDM4E | |
| SCHEMBL28611363 | 0.91 | SUCNR1 (0.50) | SUCNR1TSHRKDM4EALDH1A1 | |
| SCHEMBL9514945 | 0.83 | THRB (0.39) | SUCNR1TSHR | |
| SCHEMBL6793013 | 0.82 | SUCNR1 (0.30) | SUCNR1 | |
| SCHEMBL11298204 | 0.78 | SUCNR1 (0.43) | SUCNR1KDM4EALDH1A1 | |
| SCHEMBL6789695 | 0.76 | KDM4E (0.37) | TTRKDM4ESMN1; SMN2 | |
| SCHEMBL7683264 | 0.74 | SUCNR1 (0.39) | SUCNR1KDM4EALDH1A1 | |
| SCHEMBL731703 | 0.73 | SUCNR1 (0.50) | SUCNR1TSHRKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 345 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042084-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | GENERAL ELECTRIC TECHNOLOGY GMBH (CH) | 2026-02-12 | — | — | US | claimed |
| EP-4680369-A1 | SYSTEMS FOR CARBON DIOXIDE CAPTURE USING FUNCTIONALIZED SORBENTS AND WATER MANAGEMENT | GE Vernova Technology GmbH (CH) | 2026-01-21 | — | — | EP | claimed |
| EP-4556112-A2 | SORBENT COMPOSITIONS, SYSTEMS, AND METHODS | General Electric Technology GmbH (CH) | 2025-05-21 | — | — | EP | claimed |
| WO-2024232872-A1 | SYSTEMS FOR CARBON DIOXIDE CAPTURE USING FUNCTIONALIZED SORBENTS AND WATER MANAGEMENT | GENERAL ELECTRIC TECHNOLOGY GMBH (CH) | 2024-11-14 | — | — | WO | claimed |
| US-12090243-B2 | Compositions comprising fluid gels for tissue separation | ALEO BME, INC. (US) | 2024-09-17 | — | — | US | claimed |
| WO-2024123903-A1 | SORBENT COMPOSITIONS, SYSTEMS, AND METHODS | GE INFRASTRUCTURE TECHNOLOGY LLC (US) | 2024-06-13 | — | — | WO | claimed |
| CN-117320758-A | Composition for tissue separation comprising a fluid gel | 阿莱奥BME公司 | 2023-12-29 | — | — | CN | claimed |
| US-20220305171-A1 | COMPOSITIONS COMPRISING FLUID GELS FOR TISSUE SEPARATION | ALEO BME, INC. | 2022-09-29 | — | — | US | claimed |
| EP-2739169-B1 | POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS | MASSACHUSETTS INST TECHNOLOGY (US) | 2019-06-12 | — | — | EP | claimed |
| US-20150099289-A1 | CARBONIC ANHYDRASE XEROGEL PARTICLES | CO2 SOLUTIONS INC. (CA) | 2015-04-09 | — | — | US | claimed |
| US-20130267004-A1 | POLYSILICATE-POLYSILICONE ENZYME IMMOBILIZATION MATERIALS | AKERMIN, INC. (US) | 2013-10-10 | — | — | US | claimed |
| WO-2013019865-A2 | POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2013-02-07 | — | — | WO | claimed |
| US-6818778-B2 | HYDROLYSIS OF OCTAETHYL(-)-(18-CROWN-6)-2,3,11,12-TETRACARBOXAMIDE OBTAINED BY CONDENSATION OF N,N,N',N'-TETRAALKYL-D-TARTARAMIDE WITH DIHALO- OR DISULFONYLOXY- DIETHYL ETHER | RSTECH CO., LTD. (KR) | 2004-11-16 | — | — | US | claimed |
| US-20040104124-A1 | Plating bath and method for depositing a metal layer on a substrate | SHIPLEY COMPANY, L.L.C. | 2004-06-03 | — | — | US | claimed |
| US-20040044231-A1 | Process for preparing (-)-(18-crown-6)-2,3,11,12-tetracarboxylic acid, and (-)-chiral stationary phases for resolution of racemic compounds using the same | RSTECH CO., LTD. (KR) | 2004-03-04 | — | — | US | claimed |
| EP-1308540-A1 | Plating bath and method for depositing a metal layer on a substrate | Shipley Co. L.L.C. (US) | 2003-05-07 | — | — | EP | claimed |
| US-20030070934-A1 | Plating bath and method for depositing a metal layer on a substrate | SHIPLEY COMPANY, L.L.C. | 2003-04-17 | — | — | US | claimed |
| US-6211389-B1 | TREATING SPECIFICALLY DEFINED COMBINATIONS COMPRISING AN EPOXY RESIN STARTING MATERIAL AND OTHER COMPONENTS TO ORGANIC SOLVENT, A CROWN ETHER, AND A SUITABLE BASE TO CONDITIONS SUFFICIENT TO PRODUCE A TREATED EPOXY COMPOUND | DEXTER CORPORATION | 2001-04-03 | — | — | US | claimed |
| US-5296475-A | Methanediphosphonic acids and crown compounds for treatment of bone disorders or hypercalcemia | CIBA-GEIGY CORPORATION (US) | 1994-03-22 | — | — | US | claimed |
| EP-0550385-A1 | Oral pharmaceutical compositions containing derivatives of methane-diphosphonic acid and 18-crown-6 ethers | CIBA-GEIGY AG (CH) | 1993-07-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040044231-A1 | Process for preparing (-)-(18-crown-6)-2,3,11,12-tetracarboxylic acid, and (-)-chiral stationary phases for resolution of racemic compounds using the same | CCR6, CCR1, CCR9 | SUCNR1 997/4885HSD17B10 319/4885TTR 991/4885 |
| US-20260042084-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | SRMS, TYRO3, SELE | SUCNR1 437/4885HSD17B10 4639/4885TTR 2122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.